Oregon Department of Corrections
Approved Formulary
Search by name
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Hazardous Drugs
In-Cell HD
Earned In-Cell
Formulary Duration Restrictions
Therapeutic Substitutions
Webpage Links
Add Formweb to your mobile device
Android
iOS
Home
QuickStart
Admin
February P&T meeting minutes have been posted.
Oregon Department of Corrections
Approved Formulary
Search by name
Additional search options
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Hazardous Drugs
In-Cell HD
Earned In-Cell
Formulary Duration Restrictions
Therapeutic Substitutions
Webpage Links
Search results for:
tamoxifen
tamoxifen
Hazardous Drugs
Handling Guide (Group 1: Antineoplastic)
Cell Status
NFISA
Brand names:
Nolvadex, Tamoxifen Citrate
Form
Strength
TABLET, ORAL
10 mg; 20 mg
Additional Information:
NOVEMBER 2014 P&T MINUTES
Last updated:
Mar. 10, 2023
Black Box Warning:
Women at high risk for breast cancer; women with DCIS
UpToDate
Micromedex
Pharmacist's Letter
FDA DailyMed Package Insert
WebMD Pill Identifier
NOVEMBER 2014 P&T MINUTES